| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.5M | +21.1% |
| Cost of Revenue | $41.6M | +23.0% |
| R&D Expense | $2.7M | -3.0% |
| SG&A Expense | $25.6M | +4.7% |
| Operating Income | -$73.5M | -24.3% |
| Interest Expense | $7.1M | +66.4% |
| Pre-tax Income | -$82.0M | -13.8% |
| Income Tax | $24K | +116.0% |
| Net Income | -$82.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $429K | -98.0% |
| Accounts Receivable | $1.3M | +198.2% |
| Current Assets | $11.2M | -64.9% |
| Total Assets | $41.2M | -23.3% |
| Current Liabilities | $70.7M | +64.5% |
| Total Liabilities | $80.1M | +30.2% |
| Stockholders' Equity | -$39.9M | -407.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.1M | -0.2% |
| Investing Cash Flow | -$6.5M | +44.1% |
| Financing Cash Flow | $29.6M | -61.0% |
| -14.0% |